Astera Labs, Inc. $ALAB Stock Sold by Fairvoy Private Wealth LLC

Fairvoy Private Wealth LLC lowered its position in Astera Labs, Inc. (NASDAQ:ALAB) by 54.8% during the 3rd quarter, Holdings Channel reports. The firm owned 1,623 shares of the company’s stock after selling 1,969 shares during the quarter. Fairvoy Private Wealth LLC’s holdings in Astera Labs were worth $578,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of ALAB. Keating Financial Advisory Services Inc. bought a new stake in Astera Labs during the 2nd quarter valued at $25,000. Archer Investment Corp bought a new position in shares of Astera Labs during the 2nd quarter worth $30,000. Transamerica Financial Advisors LLC bought a new position in shares of Astera Labs during the 2nd quarter worth $35,000. Continuum Advisory LLC bought a new position in shares of Astera Labs during the 2nd quarter worth $37,000. Finally, GK Wealth Management LLC purchased a new position in shares of Astera Labs during the third quarter valued at $29,000. 60.47% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on the company. Zacks Research lowered Astera Labs from a “strong-buy” rating to a “hold” rating in a research note on Monday, October 5th. UBS Group reaffirmed a “neutral” rating and issued a $425.00 price objective on shares of Astera Labs in a research note on Wednesday, August 5th. Morgan Stanley upped their price objective on shares of Astera Labs to $335.00 and gave the stock an “overweight” rating in a research note on Monday, August 3rd. Royal Bank Of Canada increased their target price on shares of Astera Labs from $425.00 to $500.00 and gave the stock an “outperform” rating in a report on Wednesday, August 5th. Finally, Jefferies Financial Group increased their target price on shares of Astera Labs from $270.00 to $450.00 and gave the stock a “buy” rating in a report on Wednesday, August 5th. Eleven research analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the stock. Based on data from MarketBeat, Astera Labs has an average rating of “Moderate Buy” and an average price target of $348.33.

Astera Labs Stock Up 0.3%

ALAB stock traded up $0.76 during trading on Monday, hitting $286.58. 2,856,952 shares of the company’s stock traded hands, compared to its average volume of 5,151,183. The firm has a market capitalization of $49.72 billion, a P/E ratio of 141.87 and a beta of 3.68. Astera Labs, Inc. has a 1 year low of $97.89 and a 1 year high of $499.48. The business has a fifty day simple moving average of $314.86 and a two-hundred day simple moving average of $298.39.

Astera Labs (NASDAQ:ALAB) last posted its earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share for the quarter, topping analysts’ consensus estimates of $0.69 by $0.11. The company had revenue of $392.40 million during the quarter, compared to analyst estimates of $360.85 million. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%. Astera Labs’s revenue was up 104.5% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.44 earnings per share. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, equities research analysts predict that Astera Labs, Inc. will post 2.70 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, Director Stefan A. Dyckerhoff sold 8,994 shares of the company’s stock in a transaction on Wednesday, September 2nd. The stock was sold at an average price of $274.96, for a total transaction of $2,472,990.24. Following the completion of the sale, the director directly owned 3,309 shares in the company, valued at $909,842.64. This represents a 73.10% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Manuel Alba sold 183,000 shares of the company’s stock in a transaction on Tuesday, September 1st. The stock was sold at an average price of $280.13, for a total value of $51,263,790.00. Following the sale, the director owned 253,863 shares of the company’s stock, valued at $71,114,642.19. This trade represents a 41.89% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders sold 408,558 shares of company stock worth $127,306,034. Insiders own 10.40% of the company’s stock.

Astera Labs Profile

Astera Labs, Inc is a semiconductor and connectivity solutions company that develops hardware and software for data centers, cloud computing, and artificial intelligence infrastructure. Its products are designed to help move data between processors, memory, storage, and networking components while addressing bandwidth, latency, and system-management requirements.

The company’s portfolio includes Aries PCI Express and Compute Express Link (CXL) Smart Retimers, Taurus Ethernet Smart Cable Modules, Scorpio Smart Fabric Switches, and Leo CXL Memory Connectivity Controllers.